Matches in Nanopublications for { ?s ?p "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP427937.RAUsaNxAWq88I4CqzOKZ105tkOJkvgknTMZxHl-Wdx95E130_assertion description "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427937.RAUsaNxAWq88I4CqzOKZ105tkOJkvgknTMZxHl-Wdx95E130_provenance.
- NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_assertion description "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645033.RAbHM0OLm2-ojY6XTpxi7CNF97DPlCNwG4MNHrfgWFQjc130_provenance.
- assertion description "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP996480.RARTB5_u4-KZcdTMWbULGJ3uiuRGTYMINq5Cvl_kw3Fhs130_assertion description "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996480.RARTB5_u4-KZcdTMWbULGJ3uiuRGTYMINq5Cvl_kw3Fhs130_provenance.
- NP996481.RAe7C6qITiJZfXs2U3-1Za7PxrOARS2k1_pMHfKu-1yek130_assertion description "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996481.RAe7C6qITiJZfXs2U3-1Za7PxrOARS2k1_pMHfKu-1yek130_provenance.
- NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_assertion description "[Therefore, concomitant administration of HDACIs and ERK1/2 inhibitors may be a promising treatment strategy for individuals with GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP644865.RA3OrrR9gCHF6aNjvUYgOekz2ZaPSnF1nk9rkzVNWlIRU130_provenance.